Mirada Medical Releases Casebook Software Upgrade for Medical Imaging Presentations

OXFORD, UK–(Marketwire – July 6, 2010) –

Mirada Medical Limited
(“Mirada” or “the Company”)

Mirada Medical Releases Casebook Software Upgrade for Medical Imaging Presentations

Oxford, UK and Ohio, US, 6 July 2010: Mirada Medical Limited, the fast growing international company focused on advanced oncology imaging, today announces that it has released a software upgrade for Casebook (Casebook 1.1.), Mirada’s unique presentation tool for showing medical scans in Microsoft PowerPoint (“PowerPoint”).

Casebook 1.1 works as a plug-in to PowerPoint and uniquely supports fully triangulated multi-planar reconstruction (“MPR”) viewing of single or fused medical images. The new software may be used as a standalone program but also offers full integration with Mirada’s clinical products including XD3, Mirada’s powerful multi-modality image analysis application. Casebook 1.1 enables users to present case information derived from imaging studies clearly and professionally. The software also offers new image visualisation options and easy-to-use editing functions.

Commenting on today’s announcement, Chief Executive Officer, Hugh Bettesworth said: “Casebook provides an easy-to-use solution to a routine problem encountered by clinicians, researchers, academics, students and all who regularly show medical images using PowerPoint. Casebook comprehensively enhances these presentations by adding support for many of the image visualisation features which were previously the preserve of dedicated reading software.”

Casebook 1.1 is available to download free of charge from the Casebook website: www.mirada-casebook.com

About Mirada Medical

Mirada Medical Limited develops internationally recognised medical imaging analysis applications that provide clinicians with an enhanced software package for the quantification of images typically used in cancer diagnosis and treatment response assessment. Mirada Medical’s technology has broad applicability across nuclear medicine, diagnostic radiology, radiation oncology and medical oncology. Mirada Medical also markets products in neurology and cardiology. Mirada specialises in offering comprehensive and quantifiable analysis for the diagnosis, staging, treatment planning and assessment of treatment response in oncology. Mirada’s advanced technology allows medical images acquired using MRI, CT, SPECT or PET scanners to be combined into one, a process known as image fusion. Image fusion is useful in clinical interpretation as it allows different qualities of information to be combined into a single picture, for example, functional information such as metabolic activity, to be combined with anatomical information showing the precise location of pathology relative to bones and organs. This provides clinical users with a more complete picture, thereby improving the quality of information available when managing a patient’s condition. Mirada’s products are designed to support the comparison of multi-modal images acquired over any number of follow up visits by the patient, making them particularly well suited to the analysis of treatment response in longer term treatment plans such as those typical when treating cancer.

Mirada Medical was formed out of Oxford University by Professor Sir Michael Brady, one of the world’s leading medical imaging scientists. The Company is ISO 13485 certified and its technology has been supplied globally to customers in countries including the US, Japan, and Europe since 2001. Mirada’s products are sold by Mirada directly and also by major healthcare players such as McKesson, Siemens, Sectra, Carestream and Vital Images.

The Mirada team is a combination of world class scientists and exceptional engineers sourced from both Oxford University and leading blue-chip companies. For more information about Mirada Medical, please visit www.mirada-medical.com.